BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 30.954
AS - Asia 16.447
EU - Europa 12.540
SA - Sud America 3.810
Continente sconosciuto - Info sul continente non disponibili 842
AF - Africa 416
OC - Oceania 40
Totale 65.049
Nazione #
US - Stati Uniti d'America 30.365
SG - Singapore 5.478
CN - Cina 5.189
BR - Brasile 3.168
UA - Ucraina 2.453
DE - Germania 2.423
IT - Italia 2.090
HK - Hong Kong 2.038
VN - Vietnam 1.194
GB - Regno Unito 921
FR - Francia 919
PL - Polonia 875
RU - Federazione Russa 828
FI - Finlandia 817
BD - Bangladesh 760
TR - Turchia 527
IE - Irlanda 451
IN - India 389
AR - Argentina 264
CA - Canada 264
MX - Messico 173
NL - Olanda 141
SE - Svezia 135
IQ - Iraq 133
ID - Indonesia 116
ZA - Sudafrica 108
BE - Belgio 103
EC - Ecuador 99
JP - Giappone 92
AT - Austria 89
PK - Pakistan 75
ES - Italia 74
CO - Colombia 69
NG - Nigeria 64
CZ - Repubblica Ceca 62
MA - Marocco 62
SA - Arabia Saudita 60
VE - Venezuela 56
PY - Paraguay 55
UZ - Uzbekistan 53
CL - Cile 48
AU - Australia 36
KE - Kenya 33
JM - Giamaica 31
KR - Corea 31
EG - Egitto 27
IL - Israele 27
TN - Tunisia 27
LT - Lituania 25
NP - Nepal 24
AE - Emirati Arabi Uniti 23
JO - Giordania 23
PH - Filippine 23
EU - Europa 22
IR - Iran 21
KZ - Kazakistan 21
PE - Perù 21
DO - Repubblica Dominicana 19
HN - Honduras 19
MY - Malesia 18
UY - Uruguay 18
AZ - Azerbaigian 17
DZ - Algeria 17
MU - Mauritius 17
LB - Libano 16
RO - Romania 16
TH - Thailandia 15
TW - Taiwan 15
BG - Bulgaria 14
GT - Guatemala 14
CR - Costa Rica 13
ET - Etiopia 13
CH - Svizzera 12
SN - Senegal 11
BH - Bahrain 10
BY - Bielorussia 10
PS - Palestinian Territory 10
LV - Lettonia 9
CI - Costa d'Avorio 8
EE - Estonia 8
NI - Nicaragua 8
PA - Panama 8
TT - Trinidad e Tobago 8
AL - Albania 7
BO - Bolivia 7
RS - Serbia 7
XK - ???statistics.table.value.countryCode.XK??? 7
BB - Barbados 6
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
PT - Portogallo 6
SV - El Salvador 6
AM - Armenia 5
GD - Grenada 5
HR - Croazia 5
NO - Norvegia 5
OM - Oman 5
CG - Congo 4
GE - Georgia 4
Totale 64.135
Città #
Fairfield 3.708
Singapore 2.881
Woodbridge 2.818
Ashburn 2.619
Hong Kong 2.030
Houston 1.914
Jacksonville 1.774
Seattle 1.472
Cambridge 1.348
Ann Arbor 1.322
Wilmington 1.247
San Jose 1.134
The Dalles 1.049
Beijing 983
Warsaw 863
Princeton 787
New York 758
Nanjing 645
Chandler 627
Los Angeles 493
Lauterbourg 486
Helsinki 450
Dublin 448
Ho Chi Minh City 444
Istanbul 430
Dallas 423
Columbus 393
Dearborn 325
Milan 324
Munich 283
São Paulo 277
Buffalo 257
Nanchang 247
Moscow 239
Hanoi 236
Des Moines 235
Brescia 231
Redondo Beach 198
Shenyang 178
Changsha 174
Council Bluffs 173
San Diego 173
Chicago 159
Shanghai 157
Frankfurt am Main 139
San Francisco 137
Hebei 135
Santa Clara 134
Jinan 130
London 118
Rome 115
Tianjin 112
Nuremberg 111
Rio de Janeiro 106
Turku 106
Jiaxing 98
Brussels 95
Orem 95
Brooklyn 93
Lancaster 93
Belo Horizonte 85
Kunming 84
Boardman 76
Tokyo 75
Toronto 75
Phoenix 73
Montreal 71
Hangzhou 70
Guangzhou 66
Denver 65
Abuja 59
Atlanta 58
Zhengzhou 55
Mexico City 54
Verona 54
Haiphong 52
Johannesburg 52
Ningbo 50
Chennai 49
Norwalk 49
Tashkent 49
San Mateo 45
Curitiba 44
Naples 43
Porto Alegre 43
Baghdad 42
Brasília 42
Dhaka 42
Manchester 42
Nürnberg 42
Mumbai 41
Stockholm 41
Amsterdam 39
Charlotte 38
Da Nang 38
Quito 38
Vienna 38
Taizhou 37
Boston 36
Romola 36
Totale 41.317
Nome #
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 426
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 355
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 329
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. 322
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 274
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 271
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 263
A complicated case of intracranial hypotension: Diagnostic and management strategies 262
COVID-19 impact on consecutive neurological patients admitted to the emergency department 259
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 256
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 252
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 239
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 232
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 232
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 228
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 226
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 226
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 223
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 223
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 214
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 210
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 210
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 208
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 207
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 205
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 204
A case report: doctor, my daughter has Alzheimer's disease. 202
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 200
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 199
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 199
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 195
A complicated case of intracranial hypotension: diagnostic and management strategies. 191
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 191
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 190
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 188
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 187
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 187
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 185
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 184
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 183
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 182
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 182
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 182
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 181
Autoimmunity and frontotemporal dementia 181
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 180
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 180
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 179
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 177
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 175
Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study. 174
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 174
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 170
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 170
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 169
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 169
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 169
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 169
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 169
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 169
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 168
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 167
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. 167
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 166
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 166
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 165
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 165
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 165
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 164
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 164
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 164
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 164
Cardiac arrhythmias and silent myocardial ischaemia in Mild Cognitive Impairment and Alzheimer Disease 162
Vascular risk factors and cognition in Parkinson's disease 161
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 159
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 159
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 158
ELOVL5 mutations cause spinocerebellar ataxia 38. 158
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. 157
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 157
New insights into the genetic etiology of Alzheimer’s disease and related dementias 155
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 155
Alterazioni del flusso ematico cerebrale nella Malattia di Alzheimer 155
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 154
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 153
Cardiovascular structural and functional changes in Mild Cognitive Impairment and Alzheimer Disease.Potential predictive role of QT Dispersion and Heart Rate Variability Analysis 153
Frontotemporal dementia and its subtypes: A genome-wide association study 153
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 153
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 153
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 153
Dementia, delusions and seizures: storage disease or genetic AD? 152
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. 152
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 152
Association between tau H2 haplotype and age at onset in frontotemporal dementia 151
Endothelial nitric oxide synthase polymorphisms as risk factors for migraine: a response. 151
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 151
Natural history and predictors of survival in progressive supranuclear palsy. 151
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 150
Totale 19.118
Categoria #
all - tutte 314.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 314.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20259.056 79 50 88 1.262 1.015 729 824 255 934 775 1.835 1.210
2025/202620.319 1.720 2.801 1.735 3.089 1.415 1.213 2.692 806 1.238 1.610 1.266 734
2026/2027918 918 0 0 0 0 0 0 0 0 0 0 0
Totale 65.049